A serological, parasitological and clinical evaluation of untreated Chagas disease patients and those treated with benznidazole before and thirteen years after intervention

Chronic phase of Chagas disease: why should it be treated? A comprehensive review

(2014) José Rodrigues Coura et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

In-house ELISA method to analyze anti-Trypanosoma cruzi IgG reactivity for differential diagnosis and evaluation of Chagas disease morbidity

(2012) Lilian da Silva Santos et al.   Revista da Sociedade Brasileira de Medicina Tropical

Impact of Aetiological Treatment on Conventional and Multiplex Serology in Chronic Chagas Disease

(2011) Rodolfo Viotti et al.   PLoS Neglected Tropical Diseases

Clinical and laboratory status of patients with chronic Chagas disease living in a vector-controlled area in Minas Gerais, Brazil, before and nine years after aetiological treatment

(2010) Marta de Lana et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease

(2009) J Antonio Marin-Neto et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Usefulness of PCR-based assays to assess drug efficacy in Chagas disease chemotherapy: value and limitations

(2009) Constança Carvalho Britto   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Efficacy of benznidazol treatment for asymptomatic chagasic patients from state of Rio Grande do Sul evaluated during a three years follow-up

(2009) CD Fernandes et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ